SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-057326
Filing Date
2021-11-08
Accepted
2021-11-08 16:05:40
Documents
1
Period of Report
2021-11-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3993
  Complete submission text file 0001213900-21-057326.txt   5414
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Issuer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1920 MCKINNEY AVENUE, 7TH FLOOR DALLAS TX 75201
Business Address
Silberstein David S. (Reporting) CIK: 0001812659 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39318 | Film No.: 211387902